Dykens fighting cancer here and abroad

Cervical cancer is the leading cancer killer in Senegal. Andrew Dykens is working to change that. Dykens, MD, MPH, University of Illinois Cancer Center member and associate professor of family medicine at the University of Illinois College of Medicine, has worked closely with Senegal’s regional health ministry to implement a visual inspection cervical cancer screening program that he believes will help women in the West African nation discover the potentially deadly disease in…

Continue Reading

Winn delivers keynote address at AAIP annual conference

Robert A. Winn, MD, director of the University of Illinois Cancer Center, delivered the keynote speech at the 48th Association of American Indian Physicians (AAIP) Annual Conference, held last week in Chicago. The UI Cancer Center was a sponsor of the event. “From my cancer center, three to four miles away is the Loop,” Winn told those in attendance. “The life expectancy there is 85. Literally, to the west of it, there’s an…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112. NRG-LU005: Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab Sponsor: National Cancer Institute…

Continue Reading

Funding opportunity – “Bugs as Drugs”

The National Cancer Institute’s Division of Cancer Treatment and Diagnosis has a funding opportunity for microbial-based cancer therapy. Microbial-based cancer therapy has the potential as a treatment for conditions where conventional cancer therapies are inadequate. However, despite this potential, the field is not well developed and relatively little research has been done to advance research on novel microbial-based anticancer therapeutic agents by exploring the complexities of microbial-tumor interactions and microbial anti-tumor activation of…

Continue Reading